European Medicines Evaluation Agency Finds No Narcolepsy Link to GlaxoSmithKline’s Flu Vaccine

September 24, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

LONDON (Reuters) - There is no evidence to link GlaxoSmithKline's H1N1 swine flu vaccine Pandemrix to cases of narcolepsy, European drugs regulators said on Thursday, but a full review is needed and will take three to six months.

Twitter
LinkedIn
Facebook
Email
Print

Europe

GlaxoSmithKline